M&T Bank Corp grew its position in shares of Masimo Co. (NASDAQ:MASI – Free Report) by 4.9% in the 4th quarter, ...

NomoLine capnography and gas monitoring, and regional oximetry. Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and ...

Learn more about whether Masimo Corporation or STERIS plc is a better investment based on AAII's A+ Investor grades, which ...

BTIG analyst Marie Thibault raised the firm’s price target on Masimo (MASI) to $206 from $178 and keeps a Buy rating on the shares after its Q4 earnings beat. The company is moving quickly with ...

key Masimo additions include Next Generation SedLine® Brain Function Monitoring, O3® Regional Oximetry, and ISA™ Capnography with NomoLine® sampling lines. Masimo’s family of continuous and ...

Masimo Corporation MASI delivered adjusted earnings per share (EPS) of $1.80 in the fourth quarter of 2024, up 44% year over year. The figure beat the Zacks Consensus Estimate by 20.8%. Find the ...

Q4 2024 Earnings Call Transcript February 25, 2025 Masimo Corporation beats earnings expectations. Reported EPS is $1.67, expectations were $1.42. Operator: Good afternoon, ladies and gentlemen, and ...

Masimo (NASDAQ: MASI) today announced that its management will participate in the 46th Annual Raymond James Institutional Investor Conference on Tuesday, March 4, 2025 at 11:35 a.m. Eastern time. A ...

Masimo Corporation MASI delivered adjusted ... CO-Oximetry and hemodynamics, capnography and gas and brain monitoring exceeding their respective growth targets. Non-healthcare revenues in the ...

IRVINE, Calif., February 28, 2025--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the 46th Annual Raymond James Institutional Investor Conference on ...